Eisai Co., Ltd. (ESALF) Stock Competitors & Peer Comparison
See (ESALF) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ESALF | $23.88 | +0.00% | 6.7B | 28.09 | $0.85 | +4.37% |
| MKKGY | $31.74 | +0.32% | 69.7B | 23.76 | $1.35 | +1.61% |
| MKGAF | $156.15 | -2.23% | 67.9B | 23.10 | $6.76 | +1.65% |
| IPSEY | $46.75 | +3.80% | 61.8B | 30.36 | $1.54 | +0.99% |
| TKPHF | $31.30 | +2.72% | 49.4B | 41.73 | $0.75 | +4.17% |
| HLNCF | $4.46 | +3.72% | 39.5B | 17.84 | $0.25 | +2.15% |
| TEVJF | $30.34 | +0.50% | 35.3B | 22.64 | $1.34 | N/A |
| SDZNY | $81.86 | +0.96% | 35.2B | 38.92 | $2.09 | +1.25% |
| TAIPY | $14.00 | +16.67% | 18.1B | 82.35 | $0.17 | N/A |
| ESALY | $61.51 | -2.11% | 17.6B | 20.54 | $3.00 | N/A |
Stock Comparison
ESALF vs MKKGY Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, MKKGY has a market cap of 69.7B. Regarding current trading prices, ESALF is priced at $23.88, while MKKGY trades at $31.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas MKKGY's P/E ratio is 23.76. In terms of profitability, ESALF's ROE is +0.04%, compared to MKKGY's ROE of +0.09%. Regarding short-term risk, ESALF is less volatile compared to MKKGY. This indicates potentially lower risk in terms of short-term price fluctuations for ESALF.Check MKKGY's competition here
ESALF vs MKGAF Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, MKGAF has a market cap of 67.9B. Regarding current trading prices, ESALF is priced at $23.88, while MKGAF trades at $156.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas MKGAF's P/E ratio is 23.10. In terms of profitability, ESALF's ROE is +0.04%, compared to MKGAF's ROE of +0.08%. Regarding short-term risk, ESALF is less volatile compared to MKGAF. This indicates potentially lower risk in terms of short-term price fluctuations for ESALF.Check MKGAF's competition here
ESALF vs IPSEY Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, IPSEY has a market cap of 61.8B. Regarding current trading prices, ESALF is priced at $23.88, while IPSEY trades at $46.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas IPSEY's P/E ratio is 30.36. In terms of profitability, ESALF's ROE is +0.04%, compared to IPSEY's ROE of +0.10%. Regarding short-term risk, ESALF is less volatile compared to IPSEY. This indicates potentially lower risk in terms of short-term price fluctuations for ESALF.Check IPSEY's competition here
ESALF vs TKPHF Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, TKPHF has a market cap of 49.4B. Regarding current trading prices, ESALF is priced at $23.88, while TKPHF trades at $31.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas TKPHF's P/E ratio is 41.73. In terms of profitability, ESALF's ROE is +0.04%, compared to TKPHF's ROE of +0.03%. Regarding short-term risk, ESALF and TKPHF have similar daily volatility (0.00).Check TKPHF's competition here
ESALF vs HLNCF Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, HLNCF has a market cap of 39.5B. Regarding current trading prices, ESALF is priced at $23.88, while HLNCF trades at $4.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas HLNCF's P/E ratio is 17.84. In terms of profitability, ESALF's ROE is +0.04%, compared to HLNCF's ROE of +0.06%. Regarding short-term risk, ESALF is less volatile compared to HLNCF. This indicates potentially lower risk in terms of short-term price fluctuations for ESALF.Check HLNCF's competition here
ESALF vs TEVJF Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, TEVJF has a market cap of 35.3B. Regarding current trading prices, ESALF is priced at $23.88, while TEVJF trades at $30.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas TEVJF's P/E ratio is 22.64. In terms of profitability, ESALF's ROE is +0.04%, compared to TEVJF's ROE of +0.21%. Regarding short-term risk, ESALF and TEVJF have similar daily volatility (0.00).Check TEVJF's competition here
ESALF vs SDZNY Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, SDZNY has a market cap of 35.2B. Regarding current trading prices, ESALF is priced at $23.88, while SDZNY trades at $81.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas SDZNY's P/E ratio is 38.92. In terms of profitability, ESALF's ROE is +0.04%, compared to SDZNY's ROE of +0.10%. Regarding short-term risk, ESALF is less volatile compared to SDZNY. This indicates potentially lower risk in terms of short-term price fluctuations for ESALF.Check SDZNY's competition here
ESALF vs TAIPY Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, TAIPY has a market cap of 18.1B. Regarding current trading prices, ESALF is priced at $23.88, while TAIPY trades at $14.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas TAIPY's P/E ratio is 82.35. In terms of profitability, ESALF's ROE is +0.04%, compared to TAIPY's ROE of +0.02%. Regarding short-term risk, ESALF is less volatile compared to TAIPY. This indicates potentially lower risk in terms of short-term price fluctuations for ESALF.Check TAIPY's competition here
ESALF vs ESALY Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, ESALY has a market cap of 17.6B. Regarding current trading prices, ESALF is priced at $23.88, while ESALY trades at $61.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas ESALY's P/E ratio is 20.54. In terms of profitability, ESALF's ROE is +0.04%, compared to ESALY's ROE of +0.06%. Regarding short-term risk, ESALF is less volatile compared to ESALY. This indicates potentially lower risk in terms of short-term price fluctuations for ESALF.Check ESALY's competition here
ESALF vs BIOVF Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, BIOVF has a market cap of 16.4B. Regarding current trading prices, ESALF is priced at $23.88, while BIOVF trades at $47.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas BIOVF's P/E ratio is 169.11. In terms of profitability, ESALF's ROE is +0.04%, compared to BIOVF's ROE of +0.02%. Regarding short-term risk, ESALF and BIOVF have similar daily volatility (0.00).Check BIOVF's competition here
ESALF vs SGIOF Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, SGIOF has a market cap of 15B. Regarding current trading prices, ESALF is priced at $23.88, while SGIOF trades at $17.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas SGIOF's P/E ratio is 11.71. In terms of profitability, ESALF's ROE is +0.04%, compared to SGIOF's ROE of +0.14%. Regarding short-term risk, ESALF is less volatile compared to SGIOF. This indicates potentially lower risk in terms of short-term price fluctuations for ESALF.Check SGIOF's competition here
ESALF vs SGIOY Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, SGIOY has a market cap of 14.6B. Regarding current trading prices, ESALF is priced at $23.88, while SGIOY trades at $8.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas SGIOY's P/E ratio is 11.44. In terms of profitability, ESALF's ROE is +0.04%, compared to SGIOY's ROE of +0.14%. Regarding short-term risk, ESALF is less volatile compared to SGIOY. This indicates potentially lower risk in terms of short-term price fluctuations for ESALF.Check SGIOY's competition here
ESALF vs IPSEF Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, IPSEF has a market cap of 9.3B. Regarding current trading prices, ESALF is priced at $23.88, while IPSEF trades at $113.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas IPSEF's P/E ratio is 18.07. In terms of profitability, ESALF's ROE is +0.04%, compared to IPSEF's ROE of +0.12%. Regarding short-term risk, ESALF and IPSEF have similar daily volatility (0.00).Check IPSEF's competition here
ESALF vs SFOSF Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, SFOSF has a market cap of 6.9B. Regarding current trading prices, ESALF is priced at $23.88, while SFOSF trades at $2.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas SFOSF's P/E ratio is 13.68. In terms of profitability, ESALF's ROE is +0.04%, compared to SFOSF's ROE of +0.09%. Regarding short-term risk, ESALF and SFOSF have similar daily volatility (0.00).Check SFOSF's competition here
ESALF vs BCHMF Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, BCHMF has a market cap of 6.8B. Regarding current trading prices, ESALF is priced at $23.88, while BCHMF trades at $91.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas BCHMF's P/E ratio is 36.35. In terms of profitability, ESALF's ROE is +0.04%, compared to BCHMF's ROE of +0.11%. Regarding short-term risk, ESALF and BCHMF have similar daily volatility (0.00).Check BCHMF's competition here
ESALF vs ESAIY Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, ESAIY has a market cap of 6.5B. Regarding current trading prices, ESALF is priced at $23.88, while ESAIY trades at $5.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas ESAIY's P/E ratio is 27.48. In terms of profitability, ESALF's ROE is +0.04%, compared to ESAIY's ROE of +0.04%. Regarding short-term risk, ESALF is less volatile compared to ESAIY. This indicates potentially lower risk in terms of short-term price fluctuations for ESALF.Check ESAIY's competition here
ESALF vs GZPHF Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, GZPHF has a market cap of 6.2B. Regarding current trading prices, ESALF is priced at $23.88, while GZPHF trades at $2.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas GZPHF's P/E ratio is 9.00. In terms of profitability, ESALF's ROE is +0.04%, compared to GZPHF's ROE of +0.08%. Regarding short-term risk, ESALF and GZPHF have similar daily volatility (0.00).Check GZPHF's competition here
ESALF vs HLUBF Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, HLUBF has a market cap of 5.8B. Regarding current trading prices, ESALF is priced at $23.88, while HLUBF trades at $5.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas HLUBF's P/E ratio is 9.48. In terms of profitability, ESALF's ROE is +0.04%, compared to HLUBF's ROE of +0.15%. Regarding short-term risk, ESALF and HLUBF have similar daily volatility (0.00).Check HLUBF's competition here
ESALF vs HLBBF Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, HLBBF has a market cap of 5.8B. Regarding current trading prices, ESALF is priced at $23.88, while HLBBF trades at $7.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas HLBBF's P/E ratio is 14.29. In terms of profitability, ESALF's ROE is +0.04%, compared to HLBBF's ROE of +0.15%. Regarding short-term risk, ESALF and HLBBF have similar daily volatility (0.00).Check HLBBF's competition here
ESALF vs LVZPF Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, LVZPF has a market cap of 5.1B. Regarding current trading prices, ESALF is priced at $23.88, while LVZPF trades at $4.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas LVZPF's P/E ratio is 12.79. In terms of profitability, ESALF's ROE is +0.04%, compared to LVZPF's ROE of +0.14%. Regarding short-term risk, ESALF and LVZPF have similar daily volatility (0.00).Check LVZPF's competition here
ESALF vs DNPUF Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, DNPUF has a market cap of 4.7B. Regarding current trading prices, ESALF is priced at $23.88, while DNPUF trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas DNPUF's P/E ratio is 6.25. In terms of profitability, ESALF's ROE is +0.04%, compared to DNPUF's ROE of +0.42%. Regarding short-term risk, ESALF and DNPUF have similar daily volatility (0.00).Check DNPUF's competition here
ESALF vs LABFF Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, LABFF has a market cap of 4.6B. Regarding current trading prices, ESALF is priced at $23.88, while LABFF trades at $90.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas LABFF's P/E ratio is 28.95. In terms of profitability, ESALF's ROE is +0.04%, compared to LABFF's ROE of +0.21%. Regarding short-term risk, ESALF and LABFF have similar daily volatility (0.00).Check LABFF's competition here
ESALF vs SMDPY Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, SMDPY has a market cap of 4.5B. Regarding current trading prices, ESALF is priced at $23.88, while SMDPY trades at $9.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas SMDPY's P/E ratio is 5.92. In terms of profitability, ESALF's ROE is +0.04%, compared to SMDPY's ROE of +0.42%. Regarding short-term risk, ESALF and SMDPY have similar daily volatility (0.00).Check SMDPY's competition here
ESALF vs SGFEF Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, SGFEF has a market cap of 4.4B. Regarding current trading prices, ESALF is priced at $23.88, while SGFEF trades at $100.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas SGFEF's P/E ratio is 20.62. In terms of profitability, ESALF's ROE is +0.04%, compared to SGFEF's ROE of +0.16%. Regarding short-term risk, ESALF is less volatile compared to SGFEF. This indicates potentially lower risk in terms of short-term price fluctuations for ESALF.Check SGFEF's competition here
ESALF vs HKMPY Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, HKMPY has a market cap of 4.3B. Regarding current trading prices, ESALF is priced at $23.88, while HKMPY trades at $39.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas HKMPY's P/E ratio is 10.80. In terms of profitability, ESALF's ROE is +0.04%, compared to HKMPY's ROE of +0.16%. Regarding short-term risk, ESALF and HKMPY have similar daily volatility (0.00).Check HKMPY's competition here
ESALF vs HKMPF Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, HKMPF has a market cap of 4.1B. Regarding current trading prices, ESALF is priced at $23.88, while HKMPF trades at $19.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas HKMPF's P/E ratio is 10.54. In terms of profitability, ESALF's ROE is +0.04%, compared to HKMPF's ROE of +0.16%. Regarding short-term risk, ESALF and HKMPF have similar daily volatility (0.00).Check HKMPF's competition here
ESALF vs APNHY Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, APNHY has a market cap of 3.9B. Regarding current trading prices, ESALF is priced at $23.88, while APNHY trades at $8.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas APNHY's P/E ratio is -35.08. In terms of profitability, ESALF's ROE is +0.04%, compared to APNHY's ROE of -0.02%. Regarding short-term risk, ESALF and APNHY have similar daily volatility (0.00).Check APNHY's competition here
ESALF vs APNHF Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, APNHF has a market cap of 3.6B. Regarding current trading prices, ESALF is priced at $23.88, while APNHF trades at $8.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas APNHF's P/E ratio is -32.80. In terms of profitability, ESALF's ROE is +0.04%, compared to APNHF's ROE of -0.02%. Regarding short-term risk, ESALF and APNHF have similar daily volatility (0.00).Check APNHF's competition here
ESALF vs CAMRF Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, CAMRF has a market cap of 3.5B. Regarding current trading prices, ESALF is priced at $23.88, while CAMRF trades at $58.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas CAMRF's P/E ratio is 47.93. In terms of profitability, ESALF's ROE is +0.04%, compared to CAMRF's ROE of +0.16%. Regarding short-term risk, ESALF is less volatile compared to CAMRF. This indicates potentially lower risk in terms of short-term price fluctuations for ESALF.Check CAMRF's competition here
ESALF vs LBTSF Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, LBTSF has a market cap of 3.3B. Regarding current trading prices, ESALF is priced at $23.88, while LBTSF trades at $15.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas LBTSF's P/E ratio is 59.04. In terms of profitability, ESALF's ROE is +0.04%, compared to LBTSF's ROE of +0.04%. Regarding short-term risk, ESALF and LBTSF have similar daily volatility (0.00).Check LBTSF's competition here
ESALF vs INVVY Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, INVVY has a market cap of 3B. Regarding current trading prices, ESALF is priced at $23.88, while INVVY trades at $21.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas INVVY's P/E ratio is -62.42. In terms of profitability, ESALF's ROE is +0.04%, compared to INVVY's ROE of -0.42%. Regarding short-term risk, ESALF and INVVY have similar daily volatility (0.00).Check INVVY's competition here
ESALF vs CURLF Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, CURLF has a market cap of 3B. Regarding current trading prices, ESALF is priced at $23.88, while CURLF trades at $11.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas CURLF's P/E ratio is -26.71. In terms of profitability, ESALF's ROE is +0.04%, compared to CURLF's ROE of -0.13%. Regarding short-term risk, ESALF is less volatile compared to CURLF. This indicates potentially lower risk in terms of short-term price fluctuations for ESALF.Check CURLF's competition here
ESALF vs DMPHF Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, DMPHF has a market cap of 2.9B. Regarding current trading prices, ESALF is priced at $23.88, while DMPHF trades at $59.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas DMPHF's P/E ratio is 26.70. In terms of profitability, ESALF's ROE is +0.04%, compared to DMPHF's ROE of +0.21%. Regarding short-term risk, ESALF and DMPHF have similar daily volatility (0.00).Check DMPHF's competition here
ESALF vs IZQVF Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, IZQVF has a market cap of 2.9B. Regarding current trading prices, ESALF is priced at $23.88, while IZQVF trades at $20.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas IZQVF's P/E ratio is -56.68. In terms of profitability, ESALF's ROE is +0.04%, compared to IZQVF's ROE of -0.99%. Regarding short-term risk, ESALF and IZQVF have similar daily volatility (0.00).Check IZQVF's competition here
ESALF vs HYPMY Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, HYPMY has a market cap of 2.9B. Regarding current trading prices, ESALF is priced at $23.88, while HYPMY trades at $4.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas HYPMY's P/E ratio is 8.32. In terms of profitability, ESALF's ROE is +0.04%, compared to HYPMY's ROE of +0.13%. Regarding short-term risk, ESALF is less volatile compared to HYPMY. This indicates potentially lower risk in terms of short-term price fluctuations for ESALF.Check HYPMY's competition here
ESALF vs ULIHF Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, ULIHF has a market cap of 2.6B. Regarding current trading prices, ESALF is priced at $23.88, while ULIHF trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas ULIHF's P/E ratio is 8.13. In terms of profitability, ESALF's ROE is +0.04%, compared to ULIHF's ROE of +0.13%. Regarding short-term risk, ESALF and ULIHF have similar daily volatility (0.00).Check ULIHF's competition here
ESALF vs HMDCF Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, HMDCF has a market cap of 2.5B. Regarding current trading prices, ESALF is priced at $23.88, while HMDCF trades at $2.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas HMDCF's P/E ratio is 5.47. In terms of profitability, ESALF's ROE is +0.04%, compared to HMDCF's ROE of +0.41%. Regarding short-term risk, ESALF is less volatile compared to HMDCF. This indicates potentially lower risk in terms of short-term price fluctuations for ESALF.Check HMDCF's competition here
ESALF vs TCNNF Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, TCNNF has a market cap of 2.3B. Regarding current trading prices, ESALF is priced at $23.88, while TCNNF trades at $11.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas TCNNF's P/E ratio is -29.37. In terms of profitability, ESALF's ROE is +0.04%, compared to TCNNF's ROE of -0.07%. Regarding short-term risk, ESALF is less volatile compared to TCNNF. This indicates potentially lower risk in terms of short-term price fluctuations for ESALF.Check TCNNF's competition here
ESALF vs CHSYF Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, CHSYF has a market cap of 2.3B. Regarding current trading prices, ESALF is priced at $23.88, while CHSYF trades at $0.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas CHSYF's P/E ratio is 9.31. In terms of profitability, ESALF's ROE is +0.04%, compared to CHSYF's ROE of +0.09%. Regarding short-term risk, ESALF and CHSYF have similar daily volatility (0.00).Check CHSYF's competition here
ESALF vs NPNKF Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, NPNKF has a market cap of 2.2B. Regarding current trading prices, ESALF is priced at $23.88, while NPNKF trades at $32.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas NPNKF's P/E ratio is 11.87. In terms of profitability, ESALF's ROE is +0.04%, compared to NPNKF's ROE of +0.11%. Regarding short-term risk, ESALF and NPNKF have similar daily volatility (0.00).Check NPNKF's competition here
ESALF vs HTSUF Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, HTSUF has a market cap of 2B. Regarding current trading prices, ESALF is priced at $23.88, while HTSUF trades at $29.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas HTSUF's P/E ratio is 16.76. In terms of profitability, ESALF's ROE is +0.04%, compared to HTSUF's ROE of +0.07%. Regarding short-term risk, ESALF and HTSUF have similar daily volatility (0.00).Check HTSUF's competition here
ESALF vs GTBIF Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, GTBIF has a market cap of 2B. Regarding current trading prices, ESALF is priced at $23.88, while GTBIF trades at $8.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas GTBIF's P/E ratio is 16.78. In terms of profitability, ESALF's ROE is +0.04%, compared to GTBIF's ROE of +0.07%. Regarding short-term risk, ESALF is less volatile compared to GTBIF. This indicates potentially lower risk in terms of short-term price fluctuations for ESALF.Check GTBIF's competition here
ESALF vs ARSUF Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, ARSUF has a market cap of 1.9B. Regarding current trading prices, ESALF is priced at $23.88, while ARSUF trades at $26.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas ARSUF's P/E ratio is 18.55. In terms of profitability, ESALF's ROE is +0.04%, compared to ARSUF's ROE of +0.17%. Regarding short-term risk, ESALF and ARSUF have similar daily volatility (0.00).Check ARSUF's competition here
ESALF vs DUTV Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, DUTV has a market cap of 1.9B. Regarding current trading prices, ESALF is priced at $23.88, while DUTV trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas DUTV's P/E ratio is N/A. In terms of profitability, ESALF's ROE is +0.04%, compared to DUTV's ROE of -0.09%. Regarding short-term risk, ESALF is less volatile compared to DUTV. This indicates potentially lower risk in terms of short-term price fluctuations for ESALF.Check DUTV's competition here
ESALF vs TSMRF Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, TSMRF has a market cap of 1.7B. Regarding current trading prices, ESALF is priced at $23.88, while TSMRF trades at $23.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas TSMRF's P/E ratio is 10.04. In terms of profitability, ESALF's ROE is +0.04%, compared to TSMRF's ROE of +0.09%. Regarding short-term risk, ESALF and TSMRF have similar daily volatility (0.00).Check TSMRF's competition here
ESALF vs SHPHF Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, SHPHF has a market cap of 1.7B. Regarding current trading prices, ESALF is priced at $23.88, while SHPHF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas SHPHF's P/E ratio is -6.22. In terms of profitability, ESALF's ROE is +0.04%, compared to SHPHF's ROE of +0.03%. Regarding short-term risk, ESALF and SHPHF have similar daily volatility (0.00).Check SHPHF's competition here
ESALF vs NPPNY Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, NPPNY has a market cap of 1.6B. Regarding current trading prices, ESALF is priced at $23.88, while NPPNY trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas NPPNY's P/E ratio is 8.84. In terms of profitability, ESALF's ROE is +0.04%, compared to NPPNY's ROE of +0.11%. Regarding short-term risk, ESALF and NPPNY have similar daily volatility (0.00).Check NPPNY's competition here
ESALF vs MITPF Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, MITPF has a market cap of 1.6B. Regarding current trading prices, ESALF is priced at $23.88, while MITPF trades at $23.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas MITPF's P/E ratio is -10.81. In terms of profitability, ESALF's ROE is +0.04%, compared to MITPF's ROE of +4.99%. Regarding short-term risk, ESALF is less volatile compared to MITPF. This indicates potentially lower risk in terms of short-term price fluctuations for ESALF.Check MITPF's competition here
ESALF vs KARBF Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, KARBF has a market cap of 1.5B. Regarding current trading prices, ESALF is priced at $23.88, while KARBF trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas KARBF's P/E ratio is 262.50. In terms of profitability, ESALF's ROE is +0.04%, compared to KARBF's ROE of N/A. Regarding short-term risk, ESALF and KARBF have similar daily volatility (0.00).Check KARBF's competition here
ESALF vs CMOPF Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, CMOPF has a market cap of 1.5B. Regarding current trading prices, ESALF is priced at $23.88, while CMOPF trades at $87.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas CMOPF's P/E ratio is -341.10. In terms of profitability, ESALF's ROE is +0.04%, compared to CMOPF's ROE of -0.01%. Regarding short-term risk, ESALF and CMOPF have similar daily volatility (0.00).Check CMOPF's competition here
ESALF vs CASBF Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, CASBF has a market cap of 1.4B. Regarding current trading prices, ESALF is priced at $23.88, while CASBF trades at $3.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas CASBF's P/E ratio is 198.50. In terms of profitability, ESALF's ROE is +0.04%, compared to CASBF's ROE of -0.00%. Regarding short-term risk, ESALF is less volatile compared to CASBF. This indicates potentially lower risk in terms of short-term price fluctuations for ESALF.Check CASBF's competition here
ESALF vs CHIZF Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, CHIZF has a market cap of 1.4B. Regarding current trading prices, ESALF is priced at $23.88, while CHIZF trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas CHIZF's P/E ratio is -27.34. In terms of profitability, ESALF's ROE is +0.04%, compared to CHIZF's ROE of -0.01%. Regarding short-term risk, ESALF and CHIZF have similar daily volatility (0.00).Check CHIZF's competition here
ESALF vs SWGHF Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, SWGHF has a market cap of 1.3B. Regarding current trading prices, ESALF is priced at $23.88, while SWGHF trades at $11.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas SWGHF's P/E ratio is 15.57. In terms of profitability, ESALF's ROE is +0.04%, compared to SWGHF's ROE of +0.06%. Regarding short-term risk, ESALF and SWGHF have similar daily volatility (0.00).Check SWGHF's competition here
ESALF vs TWAPF Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, TWAPF has a market cap of 1.2B. Regarding current trading prices, ESALF is priced at $23.88, while TWAPF trades at $25.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas TWAPF's P/E ratio is 9.45. In terms of profitability, ESALF's ROE is +0.04%, compared to TWAPF's ROE of +0.03%. Regarding short-term risk, ESALF and TWAPF have similar daily volatility (0.00).Check TWAPF's competition here
ESALF vs EVOTF Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, EVOTF has a market cap of 1.2B. Regarding current trading prices, ESALF is priced at $23.88, while EVOTF trades at $6.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas EVOTF's P/E ratio is -5.27. In terms of profitability, ESALF's ROE is +0.04%, compared to EVOTF's ROE of -0.25%. Regarding short-term risk, ESALF and EVOTF have similar daily volatility (0.00).Check EVOTF's competition here
ESALF vs LJUIF Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, LJUIF has a market cap of 1.2B. Regarding current trading prices, ESALF is priced at $23.88, while LJUIF trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas LJUIF's P/E ratio is 13.42. In terms of profitability, ESALF's ROE is +0.04%, compared to LJUIF's ROE of +0.06%. Regarding short-term risk, ESALF and LJUIF have similar daily volatility (0.00).Check LJUIF's competition here
ESALF vs BIOGY Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, BIOGY has a market cap of 1.1B. Regarding current trading prices, ESALF is priced at $23.88, while BIOGY trades at $11.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas BIOGY's P/E ratio is 31.43. In terms of profitability, ESALF's ROE is +0.04%, compared to BIOGY's ROE of +0.26%. Regarding short-term risk, ESALF and BIOGY have similar daily volatility (0.00).Check BIOGY's competition here
ESALF vs KSPHF Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, KSPHF has a market cap of 1.1B. Regarding current trading prices, ESALF is priced at $23.88, while KSPHF trades at $25.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas KSPHF's P/E ratio is 12.45. In terms of profitability, ESALF's ROE is +0.04%, compared to KSPHF's ROE of +0.06%. Regarding short-term risk, ESALF and KSPHF have similar daily volatility (0.00).Check KSPHF's competition here
ESALF vs SHEZF Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, SHEZF has a market cap of 1.1B. Regarding current trading prices, ESALF is priced at $23.88, while SHEZF trades at $0.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas SHEZF's P/E ratio is -36.03. In terms of profitability, ESALF's ROE is +0.04%, compared to SHEZF's ROE of +0.03%. Regarding short-term risk, ESALF and SHEZF have similar daily volatility (0.00).Check SHEZF's competition here
ESALF vs GLASF Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, GLASF has a market cap of 1B. Regarding current trading prices, ESALF is priced at $23.88, while GLASF trades at $13.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas GLASF's P/E ratio is -20.00. In terms of profitability, ESALF's ROE is +0.04%, compared to GLASF's ROE of -0.26%. Regarding short-term risk, ESALF is less volatile compared to GLASF. This indicates potentially lower risk in terms of short-term price fluctuations for ESALF.Check GLASF's competition here
ESALF vs KKPCF Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, KKPCF has a market cap of 1B. Regarding current trading prices, ESALF is priced at $23.88, while KKPCF trades at $26.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas KKPCF's P/E ratio is 297.56. In terms of profitability, ESALF's ROE is +0.04%, compared to KKPCF's ROE of +0.01%. Regarding short-term risk, ESALF is less volatile compared to KKPCF. This indicates potentially lower risk in terms of short-term price fluctuations for ESALF.Check KKPCF's competition here
ESALF vs GNMLF Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, GNMLF has a market cap of 928.9M. Regarding current trading prices, ESALF is priced at $23.88, while GNMLF trades at $0.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas GNMLF's P/E ratio is 10.56. In terms of profitability, ESALF's ROE is +0.04%, compared to GNMLF's ROE of +0.11%. Regarding short-term risk, ESALF and GNMLF have similar daily volatility (0.00).Check GNMLF's competition here
ESALF vs CSWYF Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, CSWYF has a market cap of 815.8M. Regarding current trading prices, ESALF is priced at $23.88, while CSWYF trades at $1.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas CSWYF's P/E ratio is 5.14. In terms of profitability, ESALF's ROE is +0.04%, compared to CSWYF's ROE of +0.12%. Regarding short-term risk, ESALF is less volatile compared to CSWYF. This indicates potentially lower risk in terms of short-term price fluctuations for ESALF.Check CSWYF's competition here
ESALF vs TRXPF Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, TRXPF has a market cap of 690.7M. Regarding current trading prices, ESALF is priced at $23.88, while TRXPF trades at $24.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas TRXPF's P/E ratio is 25.86. In terms of profitability, ESALF's ROE is +0.04%, compared to TRXPF's ROE of +0.03%. Regarding short-term risk, ESALF and TRXPF have similar daily volatility (0.00).Check TRXPF's competition here
ESALF vs AGYTF Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, AGYTF has a market cap of 655.5M. Regarding current trading prices, ESALF is priced at $23.88, while AGYTF trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas AGYTF's P/E ratio is -13.00. In terms of profitability, ESALF's ROE is +0.04%, compared to AGYTF's ROE of +2.84%. Regarding short-term risk, ESALF and AGYTF have similar daily volatility (0.00).Check AGYTF's competition here
ESALF vs KHTRF Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, KHTRF has a market cap of 646M. Regarding current trading prices, ESALF is priced at $23.88, while KHTRF trades at $6.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas KHTRF's P/E ratio is 164.75. In terms of profitability, ESALF's ROE is +0.04%, compared to KHTRF's ROE of +0.01%. Regarding short-term risk, ESALF and KHTRF have similar daily volatility (0.00).Check KHTRF's competition here
ESALF vs YIHCF Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, YIHCF has a market cap of 643.1M. Regarding current trading prices, ESALF is priced at $23.88, while YIHCF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas YIHCF's P/E ratio is -5.00. In terms of profitability, ESALF's ROE is +0.04%, compared to YIHCF's ROE of +0.06%. Regarding short-term risk, ESALF and YIHCF have similar daily volatility (0.00).Check YIHCF's competition here
ESALF vs AIHLF Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, AIHLF has a market cap of 624.3M. Regarding current trading prices, ESALF is priced at $23.88, while AIHLF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas AIHLF's P/E ratio is 10.94. In terms of profitability, ESALF's ROE is +0.04%, compared to AIHLF's ROE of +0.15%. Regarding short-term risk, ESALF and AIHLF have similar daily volatility (0.00).Check AIHLF's competition here
ESALF vs TRSSF Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, TRSSF has a market cap of 601.9M. Regarding current trading prices, ESALF is priced at $23.88, while TRSSF trades at $1.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas TRSSF's P/E ratio is -1.32. In terms of profitability, ESALF's ROE is +0.04%, compared to TRSSF's ROE of -0.76%. Regarding short-term risk, ESALF is less volatile compared to TRSSF. This indicates potentially lower risk in terms of short-term price fluctuations for ESALF.Check TRSSF's competition here
ESALF vs BOIRF Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, BOIRF has a market cap of 553.9M. Regarding current trading prices, ESALF is priced at $23.88, while BOIRF trades at $31.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas BOIRF's P/E ratio is 14.63. In terms of profitability, ESALF's ROE is +0.04%, compared to BOIRF's ROE of +0.05%. Regarding short-term risk, ESALF is less volatile compared to BOIRF. This indicates potentially lower risk in terms of short-term price fluctuations for ESALF.Check BOIRF's competition here
ESALF vs PKBFF Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, PKBFF has a market cap of 544.7M. Regarding current trading prices, ESALF is priced at $23.88, while PKBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas PKBFF's P/E ratio is N/A. In terms of profitability, ESALF's ROE is +0.04%, compared to PKBFF's ROE of +7.96%. Regarding short-term risk, ESALF and PKBFF have similar daily volatility (0.00).Check PKBFF's competition here
ESALF vs CCHWF Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, CCHWF has a market cap of 521.3M. Regarding current trading prices, ESALF is priced at $23.88, while CCHWF trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas CCHWF's P/E ratio is -1.12. In terms of profitability, ESALF's ROE is +0.04%, compared to CCHWF's ROE of +0.42%. Regarding short-term risk, ESALF is less volatile compared to CCHWF. This indicates potentially lower risk in terms of short-term price fluctuations for ESALF.Check CCHWF's competition here
ESALF vs VRNOF Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, VRNOF has a market cap of 470.4M. Regarding current trading prices, ESALF is priced at $23.88, while VRNOF trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas VRNOF's P/E ratio is -1.31. In terms of profitability, ESALF's ROE is +0.04%, compared to VRNOF's ROE of -0.31%. Regarding short-term risk, ESALF is less volatile compared to VRNOF. This indicates potentially lower risk in terms of short-term price fluctuations for ESALF.Check VRNOF's competition here
ESALF vs PEXXF Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, PEXXF has a market cap of 463.1M. Regarding current trading prices, ESALF is priced at $23.88, while PEXXF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas PEXXF's P/E ratio is 9.00. In terms of profitability, ESALF's ROE is +0.04%, compared to PEXXF's ROE of N/A. Regarding short-term risk, ESALF and PEXXF have similar daily volatility (0.00).Check PEXXF's competition here
ESALF vs SWDCF Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, SWDCF has a market cap of 444.4M. Regarding current trading prices, ESALF is priced at $23.88, while SWDCF trades at $2.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas SWDCF's P/E ratio is 92.67. In terms of profitability, ESALF's ROE is +0.04%, compared to SWDCF's ROE of +0.01%. Regarding short-term risk, ESALF and SWDCF have similar daily volatility (0.00).Check SWDCF's competition here
ESALF vs HUMDF Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, HUMDF has a market cap of 430.9M. Regarding current trading prices, ESALF is priced at $23.88, while HUMDF trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas HUMDF's P/E ratio is 2.70. In terms of profitability, ESALF's ROE is +0.04%, compared to HUMDF's ROE of +1.07%. Regarding short-term risk, ESALF and HUMDF have similar daily volatility (0.00).Check HUMDF's competition here
ESALF vs ELTP Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, ELTP has a market cap of 386.9M. Regarding current trading prices, ESALF is priced at $23.88, while ELTP trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas ELTP's P/E ratio is 8.98. In terms of profitability, ESALF's ROE is +0.04%, compared to ELTP's ROE of +0.71%. Regarding short-term risk, ESALF is less volatile compared to ELTP. This indicates potentially lower risk in terms of short-term price fluctuations for ESALF.Check ELTP's competition here
ESALF vs CRLBF Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, CRLBF has a market cap of 322.9M. Regarding current trading prices, ESALF is priced at $23.88, while CRLBF trades at $0.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas CRLBF's P/E ratio is -2.40. In terms of profitability, ESALF's ROE is +0.04%, compared to CRLBF's ROE of -0.35%. Regarding short-term risk, ESALF is less volatile compared to CRLBF. This indicates potentially lower risk in terms of short-term price fluctuations for ESALF.Check CRLBF's competition here
ESALF vs CPHRF Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, CPHRF has a market cap of 302.9M. Regarding current trading prices, ESALF is priced at $23.88, while CPHRF trades at $11.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas CPHRF's P/E ratio is 10.07. In terms of profitability, ESALF's ROE is +0.04%, compared to CPHRF's ROE of +0.26%. Regarding short-term risk, ESALF and CPHRF have similar daily volatility (0.00).Check CPHRF's competition here
ESALF vs GUERF Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, GUERF has a market cap of 281M. Regarding current trading prices, ESALF is priced at $23.88, while GUERF trades at $22.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas GUERF's P/E ratio is 8.19. In terms of profitability, ESALF's ROE is +0.04%, compared to GUERF's ROE of +0.04%. Regarding short-term risk, ESALF and GUERF have similar daily volatility (0.00).Check GUERF's competition here
ESALF vs BHCCF Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, BHCCF has a market cap of 225.1M. Regarding current trading prices, ESALF is priced at $23.88, while BHCCF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas BHCCF's P/E ratio is -4.57. In terms of profitability, ESALF's ROE is +0.04%, compared to BHCCF's ROE of +0.29%. Regarding short-term risk, ESALF is less volatile compared to BHCCF. This indicates potentially lower risk in terms of short-term price fluctuations for ESALF.Check BHCCF's competition here
ESALF vs NIKA Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, NIKA has a market cap of 209.7M. Regarding current trading prices, ESALF is priced at $23.88, while NIKA trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas NIKA's P/E ratio is N/A. In terms of profitability, ESALF's ROE is +0.04%, compared to NIKA's ROE of +0.27%. Regarding short-term risk, ESALF and NIKA have similar daily volatility (0.00).Check NIKA's competition here
ESALF vs PLNHF Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, PLNHF has a market cap of 202M. Regarding current trading prices, ESALF is priced at $23.88, while PLNHF trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas PLNHF's P/E ratio is -3.50. In terms of profitability, ESALF's ROE is +0.04%, compared to PLNHF's ROE of +838111.55%. Regarding short-term risk, ESALF is less volatile compared to PLNHF. This indicates potentially lower risk in terms of short-term price fluctuations for ESALF.Check PLNHF's competition here
ESALF vs CBWTF Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, CBWTF has a market cap of 153.4M. Regarding current trading prices, ESALF is priced at $23.88, while CBWTF trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas CBWTF's P/E ratio is 10.93. In terms of profitability, ESALF's ROE is +0.04%, compared to CBWTF's ROE of +0.16%. Regarding short-term risk, ESALF is less volatile compared to CBWTF. This indicates potentially lower risk in terms of short-term price fluctuations for ESALF.Check CBWTF's competition here
ESALF vs COPHF Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, COPHF has a market cap of 131.7M. Regarding current trading prices, ESALF is priced at $23.88, while COPHF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas COPHF's P/E ratio is -0.02. In terms of profitability, ESALF's ROE is +0.04%, compared to COPHF's ROE of -5.75%. Regarding short-term risk, ESALF is less volatile compared to COPHF. This indicates potentially lower risk in terms of short-term price fluctuations for ESALF.Check COPHF's competition here
ESALF vs NWPN Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, NWPN has a market cap of 123.7M. Regarding current trading prices, ESALF is priced at $23.88, while NWPN trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas NWPN's P/E ratio is -0.04. In terms of profitability, ESALF's ROE is +0.04%, compared to NWPN's ROE of +0.13%. Regarding short-term risk, ESALF is less volatile compared to NWPN. This indicates potentially lower risk in terms of short-term price fluctuations for ESALF.Check NWPN's competition here
ESALF vs GRUSF Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, GRUSF has a market cap of 115.9M. Regarding current trading prices, ESALF is priced at $23.88, while GRUSF trades at $0.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas GRUSF's P/E ratio is 46.36. In terms of profitability, ESALF's ROE is +0.04%, compared to GRUSF's ROE of +0.01%. Regarding short-term risk, ESALF is less volatile compared to GRUSF. This indicates potentially lower risk in terms of short-term price fluctuations for ESALF.Check GRUSF's competition here
ESALF vs LOVFF Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, LOVFF has a market cap of 113.6M. Regarding current trading prices, ESALF is priced at $23.88, while LOVFF trades at $1.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas LOVFF's P/E ratio is 14.38. In terms of profitability, ESALF's ROE is +0.04%, compared to LOVFF's ROE of +0.09%. Regarding short-term risk, ESALF is less volatile compared to LOVFF. This indicates potentially lower risk in terms of short-term price fluctuations for ESALF.Check LOVFF's competition here
ESALF vs BIOYF Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, BIOYF has a market cap of 112.3M. Regarding current trading prices, ESALF is priced at $23.88, while BIOYF trades at $9.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas BIOYF's P/E ratio is 17.54. In terms of profitability, ESALF's ROE is +0.04%, compared to BIOYF's ROE of +0.22%. Regarding short-term risk, ESALF is less volatile compared to BIOYF. This indicates potentially lower risk in terms of short-term price fluctuations for ESALF.Check BIOYF's competition here
ESALF vs LPCUF Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, LPCUF has a market cap of 112.1M. Regarding current trading prices, ESALF is priced at $23.88, while LPCUF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas LPCUF's P/E ratio is 9.51. In terms of profitability, ESALF's ROE is +0.04%, compared to LPCUF's ROE of +0.06%. Regarding short-term risk, ESALF and LPCUF have similar daily volatility (0.00).Check LPCUF's competition here
ESALF vs CNVCF Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, CNVCF has a market cap of 109.2M. Regarding current trading prices, ESALF is priced at $23.88, while CNVCF trades at $6.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas CNVCF's P/E ratio is -5.00. In terms of profitability, ESALF's ROE is +0.04%, compared to CNVCF's ROE of +1.21%. Regarding short-term risk, ESALF and CNVCF have similar daily volatility (0.00).Check CNVCF's competition here
ESALF vs AAWH Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, AAWH has a market cap of 108.8M. Regarding current trading prices, ESALF is priced at $23.88, while AAWH trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas AAWH's P/E ratio is -0.84. In terms of profitability, ESALF's ROE is +0.04%, compared to AAWH's ROE of +5.41%. Regarding short-term risk, ESALF is less volatile compared to AAWH. This indicates potentially lower risk in terms of short-term price fluctuations for ESALF.Check AAWH's competition here
ESALF vs JUSHF Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, JUSHF has a market cap of 103M. Regarding current trading prices, ESALF is priced at $23.88, while JUSHF trades at $0.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas JUSHF's P/E ratio is -1.43. In terms of profitability, ESALF's ROE is +0.04%, compared to JUSHF's ROE of +0.66%. Regarding short-term risk, ESALF and JUSHF have similar daily volatility (0.00).Check JUSHF's competition here
ESALF vs ORXOF Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, ORXOF has a market cap of 101.9M. Regarding current trading prices, ESALF is priced at $23.88, while ORXOF trades at $2.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas ORXOF's P/E ratio is -2.27. In terms of profitability, ESALF's ROE is +0.04%, compared to ORXOF's ROE of -2.28%. Regarding short-term risk, ESALF and ORXOF have similar daily volatility (0.00).Check ORXOF's competition here
ESALF vs HLTRF Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, HLTRF has a market cap of 98.5M. Regarding current trading prices, ESALF is priced at $23.88, while HLTRF trades at $3.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas HLTRF's P/E ratio is -9.84. In terms of profitability, ESALF's ROE is +0.04%, compared to HLTRF's ROE of -0.17%. Regarding short-term risk, ESALF and HLTRF have similar daily volatility (0.00).Check HLTRF's competition here
ESALF vs MEDXF Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, MEDXF has a market cap of 92.8M. Regarding current trading prices, ESALF is priced at $23.88, while MEDXF trades at $2.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas MEDXF's P/E ratio is -143.60. In terms of profitability, ESALF's ROE is +0.04%, compared to MEDXF's ROE of -0.01%. Regarding short-term risk, ESALF and MEDXF have similar daily volatility (0.00).Check MEDXF's competition here
ESALF vs SHIEF Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, SHIEF has a market cap of 85.6M. Regarding current trading prices, ESALF is priced at $23.88, while SHIEF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas SHIEF's P/E ratio is -4.00. In terms of profitability, ESALF's ROE is +0.04%, compared to SHIEF's ROE of +1.18%. Regarding short-term risk, ESALF and SHIEF have similar daily volatility (0.00).Check SHIEF's competition here
ESALF vs ABSCF Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, ABSCF has a market cap of 78.1M. Regarding current trading prices, ESALF is priced at $23.88, while ABSCF trades at $1.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas ABSCF's P/E ratio is -37.33. In terms of profitability, ESALF's ROE is +0.04%, compared to ABSCF's ROE of +0.07%. Regarding short-term risk, ESALF and ABSCF have similar daily volatility (0.00).Check ABSCF's competition here
ESALF vs EOFBY Comparison June 2026
ESALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALF stands at 6.7B. In comparison, EOFBY has a market cap of 73.7M. Regarding current trading prices, ESALF is priced at $23.88, while EOFBY trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALF currently has a P/E ratio of 28.09, whereas EOFBY's P/E ratio is -7.67. In terms of profitability, ESALF's ROE is +0.04%, compared to EOFBY's ROE of -0.77%. Regarding short-term risk, ESALF and EOFBY have similar daily volatility (0.00).Check EOFBY's competition here